Irritable Bowel
11
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
Effect of Rate Of Delivery on Colonic Fermentation of inuliN (EON)
Microbial and Human Determinants of the Onset of IBD Flares
Psychiatric Disorders and Functional Somatic Disorders
Health Care Use and Costs of Functional Somatic Disorders
Patient-Centred Innovations for Persons With Multimorbidity - Ontario
Patient-Centred Innovations for Persons With Multimorbidity - Quebec
GutMe!: IBS and Collagen Protein Powder an Interventional Study
Fecal Microbiota Transplantation for Health Improvement (TFM3)
Effect of 6 Weeks Daily Consumption of a Cereal-based Juice Beverage on Gastrointestinal Health